Clinical Coagulation Test
From Anvita Health Wiki
More Specific Terms
- activated protein C (APC) resistance assay
- anti-factor Xa heparin assay
- coagulation factor assay
- coagulation factor II inhibitor in plasma
- coagulation factor IX inhibitor in plasma
- coagulation factor V inhibitor in plasma
- coagulation factor VII inhibitor in plasma
- coagulation factor VIII inhibitor in plasma
- coagulation factor XI inhibitor in plasma
- coagulation factor XII inhibitor in plasma
- coagulation factor XIII inhibitor in plasma
- Ecarin clotting time; reptilase time
- factor IX activity in plasma
- factor IX antigen in plasma
- factor V activity in plasma
- factor VII activity in plasma
- factor VII antigen in plasma
- factor VIIa activity in plasma
- factor VIII activity in plasma
- factor VIII antigen in plasma
- factor X activity in plasma
- factor XI activity in plasma
- factor XII activity in plasma
- factor XIII activity in plasma
- fibrin degradation products in plasma; fibrin split products in plasma (FDP, FSP)
- fibrin monomer in plasma
- fibrinogen antigen in plasma
- heparin cofactor II in plasma
- high molecular weight kininogen in plasma (Fitzgerald factor assay)
- International normalized ratio (INR)
- kaolin clotting time
- lupus anticoagulant
- partial thromboplastin time (PTT)
- plasma mixing studies
- plasminogen activity in plasma
- plasminogen antigen in plasma
- platelet factor 4 in plasma
- prekallikrein (Fletcher Factor) in plasma
- prothrombin antibody in serum/plasma
- prothrombin in plasma
- prothrombin time (PT)
- ristocetin cofactor activity
- serotonin release assay
- thrombin time (TT)
- thrombin-antithrombin complex in plasma
- tissue thromboplastin inhibition test
- von Willebrand factor (vWF) multimers in plasma
- von Willebrand factor antigen in plasma
- von Willebrand factor collagen-binding activity
- von Willebrand factor collagen-binding ratio
More General Terms
References
National Guideline Clearinghouse Coagulation. Laboratory medicine practice guidelines: evidence-based practice for point-of-care testing. ngc-guideline: [1]
